Optimizing the Use of Aspirin for the Prevention of Preeclampsia

NCT07665853 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

15160

Enrollment

OTHER

Sponsor class

Conditions

Preeclampsia

Interventions

DRUG: Discontinuation of Acetylsalicilic acid 150 mg/day at 24-28 weeks of gestation

Sponsor

Hospital Universitari Vall d'Hebron Research Institute

Collaborators

[object Object]